Literature DB >> 15058501

[The challenges of the implementation of the European Directive 2001/20/CE in the main Member States].

Christian Libersa1, Florence Berger, Soizic Courcier-Duplantier, Christine Marey.   

Abstract

Since the publication of Directive 2001/20/EC in the Official Journal of the European Communities on May 1, 2001, the Member States have been preparing its transposition into national legislation for application no later than May 2004. The discussions have proved to relate essentially to the organisation of the Ethics Committees, which must now give a single opinion per Member State, as well as to the time limits for obtaining this opinion and the authorization for a study from the competent authority. These considerations have led to proposals of shorter time limits for products at an early stage of development or involving certain diseases. Despite harmonization of the legislation, the application of the Directive does not eliminate all national differences.

Entities:  

Mesh:

Year:  2003        PMID: 15058501     DOI: 10.2515/therapie:2003089

Source DB:  PubMed          Journal:  Therapie        ISSN: 0040-5957            Impact factor:   2.070


  1 in total

1.  Which factors influence the resort to surrogate consent in stroke trials, and what are the patient outcomes in this context?

Authors:  Anne-Marie Mendyk; Julien Labreuche; Hilde Henon; Marie Girot; Charlotte Cordonnier; Alain Duhamel; Didier Leys; Régis Bordet
Journal:  BMC Med Ethics       Date:  2015-04-24       Impact factor: 2.652

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.